Wyeth Oral Contraceptive Librel NDA Will Be Filed By June, Exec Says

Librel is "about 10 weeks or less from NDA submission," Wyeth Senior VP Camardo says. Wyeth also is investigating Librel, which allows for the elimination of the menstrual cycle while the product is taken, for the treatment for premenstrual dysphoric disorder.